SPONSOR
Institut Curie
Total Trials
5
Recruiting
5
Phases
Phase 2
Conditions studied: Lung CancerBreast CancerMetastatic Breast Cancer ( HER2 Negative)Unresectable Breast CancerChildrenMedical DevicePrimary PreventionOncologyUveal MelanomaOvarian Cancer
Institut Curie is a clinical research sponsor with 5 registered studies on ClinicalTrials.gov, of which 5 are actively recruiting participants. Research covers conditions including Lung Cancer, Breast Cancer, Metastatic Breast Cancer ( HER2 Negative), Unresectable Breast Cancer.
The trial portfolio spans Phase 2 studies, reflecting a pipeline that may include early-stage safety evaluations, mid-stage efficacy assessments, and large-scale confirmatory trials. All studies listed here are sourced directly from ClinicalTrials.gov and updated daily.
Frequently Asked Questions — Institut Curie
How many clinical trials has Institut Curie sponsored?
ClinicalMetric currently tracks 5 clinical trials sponsored by Institut Curie, of which 5 are actively recruiting participants. These trials cover conditions including Lung Cancer, Breast Cancer, Metastatic Breast Cancer ( HER2 Negative). Trial counts are updated daily from ClinicalTrials.gov and reflect currently registered studies.
What therapeutic areas does Institut Curie research focus on?
Institut Curie clinical trials span Lung Cancer, Breast Cancer, Metastatic Breast Cancer ( HER2 Negative), Unresectable Breast Cancer, Children, and additional conditions. The research pipeline includes Phase 2 trials, reflecting work from early-stage safety evaluation through large-scale efficacy studies.
How do I participate in a Institut Curie clinical trial?
To participate in a Institut Curie trial, review the active studies listed on this page, check each trial's specific eligibility criteria on ClinicalTrials.gov, and contact the trial site directly—not the sponsor's headquarters. Trial sites are academic medical centers, hospitals, or specialized research clinics. Your physician can facilitate a referral. ClinicalMetric lists all Institut Curie trials with current recruitment status updated daily.
Clinical Trials by Institut Curie
NCT07357311
Recruiting
Screening and Care for Fear of Cancer Recurrence in Patients With Cancer at Institut Curie
Lung Cancer
NCT07193394 Phase 2
Recruiting
Tucatinib and Trastuzumab in HER3-mutant and HER2-not Amplified Metastatic Breast Cancer
Metastatic Breast Cancer ( HER2 Negative)
NCT05781295
Recruiting
Multicentre Randomised Study Comparing a Taurolidine Lock and a Standard Saline Lock in Paediatric Oncology
Children
NCT04424719
Recruiting
Follow-up of Patients With Uveal Melanoma Adapted to the Risk of Relapse (SALOME)
Uveal Melanoma
NCT03017573
Recruiting
Prospective Biobanking Study in Cancer Patients Aiming at Better Understand the Link Between the Molecular Alterations of the Tumor Itself, Its Microenvironment and Immune Response (SCANDARE)
Ovarian Cancer
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: April 2026 · Data Methodology